<正> In recent years, islet transplantation for diabetes hasshown signs of the treatment efficacy, but itsapplication is limited due to lack of donor organizations,sources and immune rejection. Bone marrow mesenchymalstem cells (BMSCs) have become a new resource of isletcell substitutes. One focus of the current research is the
展开▼
机译:Combined Treatment with Bone Marrow-Derived Mesenchymal Stem Cells and Exendin-4 Promotes Islet Regeneration in Streptozotocin-Induced Diabetic Rats